CTC Bio Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
935
3,552
2,717
2,739
20,603
Depreciation, Depletion & Amortization
1,913
1,865
3,119
3,613
4,721
Other Funds
3
-
-
-
-
Funds from Operations
2,591
2,335
7,037
581
4,492
Changes in Working Capital
866
1,903
7,064
4,397
2,220
Net Operating Cash Flow
1,655
432
27
4,977
2,272
Capital Expenditures
6,635
27,856
23,758
13,645
5,120
Sale of Fixed Assets & Businesses
8
133
39
2,819
476
Purchase/Sale of Investments
24,896
22,877
2,652
4,661
4,919
Net Investing Cash Flow
30,261
4,846
23,527
6,056
4,356
Issuance/Reduction of Debt, Net
4,629
12,216
15,596
3,387
6,772
Net Financing Cash Flow
22,238
10,447
15,596
3,907
7,812
Net Change in Cash
6,370
5,159
7,982
2,846
1,184
Free Cash Flow
4,392
28,250
23,737
8,485
6,356
Net Assets from Acquisitions
16
-
20
-
173
Other Sources
1,613
-
-
109
5,610
Change in Capital Stock
26,865
1,769
-
520
1,040
Exchange Rate Effect
2
10
25
17
-
Other Uses
335
-
2,439
-
231
Extraordinaries
71
-
-
-
-

About CTC Bio

View Profile
Address
6th Floor, Sambo Building
Seoul SL 05724
Korea, Republic Of
Employees -
Website http://www.ctcbio.com
Updated 09/14/2018
CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants.